BMS and Eurofins invest in Indian pharma hubs Andhra Pradesh and Telangana
Facilities in Andhra Pradesh and Telangana accounted for 23% of all sites in India, confirming the area as a key pharma manufacturing hub.
Facilities in Andhra Pradesh and Telangana accounted for 23% of all sites in India, confirming the area as a key pharma manufacturing hub.
What's Your Reaction?
